Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-19

Clinical Trial Update: Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients

View source ↗

Summary

This clinical trial evaluated raltegravir in combination with optimized background therapy in multiple experienced HIV-infected patients; the study is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Raltegravir (raltegravir)

Snippet

Sponsor: Doroana, Maria Manuela, M.D. | Conditions: HIV Infections | Status: COMPLETED | Results posted: 2011-05-19